Ablative Therapy for Esophageal Dysplasia and Early Malignancy: Focus on RFA

Table 3

Esophageal RFA results summary.

Series	Mean/median length of BE (cm)	Mean/median number of treatments required	Follow-up interval (months)	Complete eradication of intestinal metaplasia (%)	Complete eradication of low-grade dysplasia (%)	Complete eradication of high-grade dysplasia (%)	Rates of progression	Complication rates (%)
Ganz et al., 2008 [28]	6	1	12	54.3	80.4	90.2	—	0.7
Fleischer et al., 2008 [37]	3.2	1.5	30	97	—	—	—	0
Shaheen et al., 2009 [29]	5.3*	Up to 4	12	77.4	90.5	81.0	4	6.0
Fleischer et al., 2010 [38]	3.2	3.4	60	92	—	—	—	0
Lyday et al., 2010 [30]	3	1.8–2.1	20	77	100	—	—	1.1

∗5.3 is mean and for HGD, 4.6 for LGD.